119 | Humans |
89 | Animals |
49 | Female |
43 | Male |
37 | Coronavirus Infections (epidemiology) |
26 | Adult |
24 | Coronavirus Infections (transmission) |
24 | Coronavirus Infections (diagnosis) |
22 | Coronavirus Infections (virology) |
20 | Coronavirus |
19 | Middle Aged |
17 | Human |
16 | Pneumonia, Viral (epidemiology) |
16 | Mice |
16 | Child |
16 | Cattle |
16 | Aged |
14 | Coronavirus Infections (veterinary) |
14 | Child, Preschool |
13 | Microbiology |
13 | Coronavirus Infections (prevention & control) |
12 | Rats |
12 | Infant |
12 | Disease Outbreaks |
12 | China |
12 | Adolescent |
11 | Young Adult |
11 | Pneumonia, Viral (diagnosis) |
11 | Antiviral Agents (pharmacology) |
10 | Viral disease |
10 | Time Factors |
10 | Pneumonia, Viral (transmission) |
10 | China (epidemiology) |
10 | Antibodies, Viral (blood) |
9 | Severe Acute Respiratory Syndrome (virology) |
9 | Respiratory Tract Infections (epidemiology) |
9 | Molecular Sequence Data |
9 | Middle East Respiratory Syndrome Coronavirus |
9 | Infant, Newborn |
9 | Antibodies, Viral (analysis) |
9 | Amino Acid Sequence |
8 | Severe acute respiratory syndrome |
8 | Severe Acute Respiratory Syndrome (epidemiology) |
8 | Severe Acute Respiratory Syndrome (diagnosis) |
8 | SARS Virus (genetics) |
8 | Respiratory Tract Infections (virology) |
8 | Prevalence |
8 | Coronavirus (isolation & purification) |
8 | Betacoronavirus |
8 | Antiviral |
7 | Virus |
7 | Virus Diseases (virology) |
7 | Swine |
7 | Structure-Activity Relationship |
7 | Retrospective Studies |
7 | Respiratory Tract Infections (veterinary) |
7 | Radiography, Thoracic |
7 | Pneumonia, Viral (prevention & control) |
7 | Phylogeny |
7 | Murine hepatitis virus |
7 | Global Health |
7 | Genome, Viral |
7 | Coronavirus Infections |
7 | Cell Line |
7 | Cattle Diseases (epidemiology) |
7 | Antigens, Viral (analysis) |
6 | Virus Diseases (epidemiology) |
6 | Virology |
6 | Viral Proteins (genetics) |
6 | Vaccine |
6 | Spike Glycoprotein, Coronavirus |
6 | Species Specificity |
6 | SARS Virus (immunology) |
6 | Respiratory disease |
6 | Respiratory Syncytial Virus Infections (epidemiology) |
6 | Protein |
6 | Protein Binding |
6 | Polymerase Chain Reaction |
6 | Pneumonia, Viral (therapy) |
6 | Lung (virology) |
6 | Human papillomavirus |
6 | Detection |
6 | Coronavirus Infections (therapy) |
6 | Coronavirus Infections (pathology) |
6 | Cattle Diseases (virology) |
6 | Cats |
6 | Antiviral Agents (chemistry) |
6 | Antiviral Agents (chemical synthesis) |
6 | Aged, 80 and over |
5 | World Health Organization |
5 | Virus Replication |
5 | Viral Proteins (immunology) |
5 | Viral Proteins (chemistry) |
5 | Viral Envelope Proteins (chemistry) |
5 | Tomography, X-Ray Computed |
5 | Sequence Alignment |
5 | Sensitivity and Specificity |
5 | Saudi Arabia |
5 | Saudi Arabia (epidemiology) |
5 | SARS Virus (isolation & purification) |
5 | Respiratory tract |
5 | Prognosis |
5 | Pneumonia, Viral |
5 | Middle East Respiratory Syndrome Coronavirus (isolation & purification) |
5 | Infection |
5 | In vitro |
5 | Fluorescent Antibody Technique |
5 | Dogs |
5 | Disease Outbreaks (prevention & control) |
5 | Cross-Sectional Studies |
5 | Coronavirus Infections (immunology) |
5 | Coronavirus Infections (complications) |
5 | Coronavirus (genetics) |
5 | Coronaviridae (isolation & purification) |
5 | Coronaviridae (immunology) |
5 | Cattle Diseases (diagnosis) |
5 | Betacoronavirus (pathogenicity) |
5 | Age Factors |
4 | coronavirus |
4 | Viruses (isolation & purification) |
4 | Virus Replication (drug effects) |
4 | Virus Diseases (veterinary) |
4 | Virus Cultivation |
4 | Veterinary |
4 | United States |
4 | T-Lymphocytes, Cytotoxic (immunology) |
4 | Severe acute respiratory syndrome virus |
4 | Severe Acute Respiratory Syndrome (transmission) |
4 | Severe Acute Respiratory Syndrome (prevention & control) |
4 | Seroepidemiologic Studies |
4 | SARS Virus (physiology) |
4 | SARS Virus (pathogenicity) |
4 | SARS Virus (chemistry) |
4 | Risk Factors |
4 | Respiratory Tract Infections (microbiology) |
4 | RNA, Viral (genetics) |
4 | Protein Structure, Secondary |
4 | Population Surveillance |
4 | Pneumonia, Viral (virology) |
4 | Pneumonia (virology) |
4 | Peptides (chemistry) |
4 | Pandemics (prevention & control) |
4 | Neutralization Tests |
4 | Murine hepatitis virus (immunology) |
4 | Multiple sclerosis |
4 | Mouse |
4 | Models, Molecular |
4 | Microscopy, Electron |
4 | Mice, Inbred C57BL |
4 | Mice, Inbred BALB C |
4 | Magnetic Resonance Spectroscopy |
4 | Incidence |
4 | Immunization |
4 | Immunity |
4 | Human immunodeficiency virus |
4 | Host-Pathogen Interactions |
4 | Feces (microbiology) |
4 | Epidemiology |
4 | Enzyme-Linked Immunosorbent Assay |
4 | Demyelination |
4 | Cytokine |
4 | Coronavirus Infections (drug therapy) |
4 | Coronavirus (classification) |
4 | Coronaviridae Infections (veterinary) |
4 | Coronaviridae Infections (pathology) |
4 | Coronaviridae Infections (diagnosis) |
4 | Contact Tracing |
4 | Cluster Analysis |
4 | Circular Dichroism |
4 | Chickens |
4 | Cattle Diseases (microbiology) |
4 | Cat |
4 | Camelus (virology) |
4 | Base Sequence |
4 | Asthma |
4 | Algorithms |
4 | Acute Disease |
4 | AIDS |
3 | multiple sclerosis |
3 | Zoonoses |
3 | Viruses (genetics) |
3 | Viruses (classification) |
3 | Virus Diseases (diagnosis) |
3 | Viral Vaccines (immunology) |
3 | Viral Proteins (metabolism) |
3 | Viral Fusion Proteins |
3 | Viral Envelope Proteins (genetics) |
3 | Vero Cells |
3 | United States (epidemiology) |
3 | Travel |
3 | Swine Diseases (virology) |
3 | Sweden (epidemiology) |
3 | Surveys and Questionnaires |
3 | Severe |
3 | Severe Acute Respiratory Syndrome (therapy) |
3 | Severe Acute Respiratory Syndrome (pathology) |
3 | Sequence Homology, Amino Acid |
3 | SARS Virus (metabolism) |
3 | SARS Virus (drug effects) |
3 | Rotavirus |
3 | Review |
3 | Reverse Transcriptase Polymerase Chain Reaction |
3 | Respiratory Syncytial Virus Infections (virology) |
3 | Respiratory Syncytial Virus Infections (veterinary) |
3 | Republic of Korea (epidemiology) |
3 | Reproducibility of Results |
3 | Remyelination |
3 | Rabbits |
3 | RNA, Viral (analysis) |
3 | Protein Structure, Tertiary |
3 | Protein Folding |
3 | Pregnancy |
3 | Practice Guidelines as Topic |
3 | Poultry Diseases (virology) |
3 | Polymerase chain reaction |
3 | Pneumonia |
3 | Pneumonia, Viral (diagnostic imaging) |
3 | Pneumonia, Viral (complications) |
3 | Pneumonia (diagnosis) |
3 | Pediatrics |
3 | Paramyxoviridae Infections (epidemiology) |
3 | Pandemics |
3 | Open Reading Frames |
3 | Oligodendrocyte |
3 | Nanoparticle |
3 | Multiplex polymerase chain reaction |
3 | Monoclonal antibody |
3 | Molecular Dynamics Simulation |
3 | Models, Statistical |
3 | Models, Biological |
3 | Membrane Glycoproteins (immunology) |
3 | Lung (pathology) |
3 | Influenza |
3 | Influenza, Human (epidemiology) |
3 | India |
3 | Immune response |
3 | Genital system |
3 | Gene therapy |
3 | Fever (virology) |
3 | Fatal Outcome |
3 | Encephalon |
3 | Drug Design |
3 | Diarrhea (veterinary) |
3 | Diagnosis, Differential |
3 | DNA, Viral (analysis) |
3 | Cytopathogenic Effect, Viral |
3 | Cough (virology) |
3 | Coronavirus, Bovine (immunology) |
3 | Coronavirus Infections (psychology) |
3 | Coronavirus Infections (physiopathology) |
3 | Coronavirus Infections (diagnostic imaging) |
3 | Coronavirus (immunology) |
3 | Coronaviridae Infections (immunology) |
3 | Computational Biology (methods) |
3 | Comparative study |
3 | Chlorocebus aethiops |
3 | Chemical synthesis |
3 | Cattle Diseases (etiology) |
3 | COVID-19 |
3 | Bronchoalveolar Lavage Fluid (virology) |
3 | Bronchoalveolar Lavage Fluid (microbiology) |
3 | Bovine |
3 | Biomarkers (blood) |
3 | Binding Sites |
3 | Betacoronavirus (isolation & purification) |
3 | Betacoronavirus (genetics) |
3 | Bacterial Infections (veterinary) |
3 | Astrocyte |
3 | Antiviral Agents (therapeutic use) |
3 | Antibodies, Bacterial (analysis) |
3 | Animal model |
3 | Animal Husbandry |
2 | virus |
2 | parotid gland |
2 | mAb |
2 | influenza |
2 | financial volatility |
2 | cytokines |
2 | common cold |
2 | basement membrane |
2 | asthma |
2 | Zoonoses (virology) |
2 | Zoonoses (epidemiology) |
2 | Virus multiplication |
2 | Virus Physiological Phenomena |
2 | Virulence |
2 | Viral Structural Proteins (genetics) |
2 | Viral Proteins (physiology) |
2 | Viral Proteins (analysis) |
2 | Viral Load |
2 | Viral Envelope Proteins (metabolism) |
2 | Viral Envelope Proteins (immunology) |
2 | Vigna unguiculata |
2 | Vector |
2 | Vaccines, DNA (genetics) |
2 | Treatment |
2 | Travel-Related Illness |
2 | Transplantation |
2 | Transmissible gastroenteritis virus (isolation & purification) |
2 | Transmissible gastroenteritis virus (genetics) |
2 | Transduction |
2 | Torovirus |
2 | Tonsillectomy |
2 | Toll-Like Receptor 7 (immunology) |
2 | Tertiary Care Centers |
2 | Temperature |
2 | TNF |
2 | TCR |
2 | T-Lymphocyte |
2 | T cells |
2 | Syndrome |
2 | Swine Diseases (microbiology) |
2 | Sweden |
2 | Survival Rate |
2 | Substrate Specificity |
2 | Structure activity relation |
2 | Strain |
2 | Spectrometry, Fluorescence |
2 | Specimen Handling |
2 | Software |
2 | Signal Transduction |
2 | Severe Acute Respiratory Syndrome (physiopathology) |
2 | Severe Acute Respiratory Syndrome (metabolism) |
2 | Severe Acute Respiratory Syndrome (diagnostic imaging) |
2 | Serologic Tests (methods) |
2 | Sequence Homology, Nucleic Acid |
2 | Sequence Analysis, DNA |
2 | Sensitivity |
2 | Schwann cell |
2 | SARS, severe acute respiratory syndrome |
2 | SARS Virus |
2 | SARS Virus (growth & development) |
2 | Rotavirus Infections (veterinary) |
2 | Rotavirus Infections (diagnosis) |
2 | Risk |
2 | Rhinovirus |
2 | Rhinovirus (pathogenicity) |
2 | Reverse transcription polymerase chain reaction |
2 | Reverse Transcriptase Polymerase Chain Reaction (methods) |
2 | Respiratory Tract Infections (physiopathology) |
2 | Respiratory Tract Infections (etiology) |
2 | Respiratory Tract Diseases (virology) |
2 | Respiratory Tract Diseases (veterinary) |
2 | Respiratory Tract Diseases (immunology) |
2 | Respiratory System (virology) |
2 | Respiratory Syncytial Virus Infections (transmission) |
2 | Respiratory Syncytial Virus Infections (physiopathology) |
2 | Resistance |
2 | Recombination, Genetic |
2 | Recombinant Proteins |
2 | Recipient |
2 | Real-Time Polymerase Chain Reaction |
2 | Random Allocation |
2 | RNA Viruses (isolation & purification) |
2 | RNA Interference |
2 | Public Health Surveillance |
2 | Proteolysis |
2 | Protein Multimerization |
2 | Protein Conformation |
2 | Prevention |
2 | Poultry Diseases (immunology) |
2 | Porcine transmissible gastroenteritis virus |
2 | Polymerase Chain Reaction (methods) |
2 | Politics |
2 | Pneumonia, Viral (pathology) |
2 | Pneumonia, Viral (mortality) |
2 | Pneumonia, Viral (drug therapy) |
2 | Picornaviridae Infections (epidemiology) |
2 | Pharyngitis |
2 | Peptidyl-Dipeptidase A (metabolism) |
2 | Peptides (immunology) |
2 | Peptides (chemical synthesis) |
2 | Peptide Fragments (pharmacology) |
2 | Peptide Fragments (chemistry) |
2 | Patient Isolation |
2 | Patient Care Planning |
2 | Pathogenesis |
2 | Particle |
2 | Paramyxoviridae Infections (virology) |
2 | Paramyxoviridae Infections (physiopathology) |
2 | Palatine Tonsil (pathology) |
2 | Oligodendrocytes |
2 | Nictitating Membrane (microbiology) |
2 | Neutralization test |
2 | Neural Networks, Computer |
2 | Mycoplasma Infections (veterinary) |
2 | Mycoplasma (isolation & purification) |
2 | Murine coronavirus |
2 | Molecular Structure |
2 | Molecular Epidemiology |
2 | Middle East Respiratory Syndrome Coronavirus (genetics) |
2 | Middle East (epidemiology) |
2 | Microglia |
2 | Microbial Sensitivity Tests |
2 | Mice, SCID |
2 | Mice, Knockout |
2 | Method |
2 | Metabolic inactivation |
2 | Membrane protein |
2 | Membrane Proteins (genetics) |
2 | Membrane Proteins (chemistry) |
2 | Membrane Glycoproteins (metabolism) |
2 | Membrane Glycoproteins (genetics) |
2 | Membrane Glycoproteins (chemistry) |
2 | Mass Spectrometry |
2 | Magnetic Resonance Imaging |
2 | Macrophages (virology) |
2 | Macrophages (immunology) |
2 | MHC |
2 | MBP |
2 | Lung |
2 | Lung Diseases (immunology) |
2 | Lung (microbiology) |
2 | Lung (metabolism) |
2 | Lung (immunology) |
2 | Lung (diagnostic imaging) |
2 | Liver (pathology) |
2 | Lipid Bilayers (metabolism) |
2 | Kinetics |
2 | Japan |
2 | Intestines (pathology) |
2 | International Health Regulations |
2 | Information Dissemination |
2 | Inflammation |
2 | Infectious bronchitis virus (physiology) |
2 | Infectious bronchitis virus (isolation & purification) |
2 | Infections |
2 | Infant, Newborn, Diseases (etiology) |
2 | In vivo |
2 | Immunosuppression |
2 | Immunoprophylaxis |
2 | Immunoglobulin G (blood) |
2 | Immunofluorescence |
2 | Immunocompetence |
2 | Immunity, Innate |
2 | IgG |
2 | Hypertrophy |
2 | Hydrophobic and Hydrophilic Interactions |
2 | Hospitalization |
2 | Hepacivirus (drug effects) |
2 | Hematopoietic Stem Cell Transplantation (adverse effects) |
2 | Hemagglutinins, Viral (physiology) |
2 | Hemagglutinins, Viral (immunology) |
2 | Hemagglutinins, Viral (analysis) |
2 | Hemagglutinin |
2 | Hemagglutination Inhibition Tests |
2 | Hemagglutination Inhibition Tests (veterinary) |
2 | Health Planning |
2 | HIV-1 virus |
2 | Guinea Pigs |
2 | Genotype |
2 | Genetic vaccine |
2 | Genetic Vectors |
2 | Genes, Viral |
2 | Gene expression |
2 | Gene Expression Regulation |
2 | France |
2 | Follow-Up Studies |
2 | Fluorescent Dyes |
2 | Fever (epidemiology) |
2 | Feline infectious peritonitis virus |
2 | Esterases |
2 | Escherichia coli Infections (veterinary) |
2 | Epitopes, T-Lymphocyte |
2 | Epithelial Cells (virology) |
2 | Epidemics |
2 | Enzyme-Linked Immunosorbent Assay (methods) |
2 | Enterocolitis, Pseudomembranous (microbiology) |
2 | Enterocolitis, Pseudomembranous (etiology) |
2 | Enteritis (veterinary) |
2 | Encephalomyelitis (pathology) |
2 | Drug Therapy, Combination |
2 | Dog |
2 | Distribution |
2 | Disease Reservoirs (virology) |
2 | Disease Reservoirs (veterinary) |
2 | Disease Progression |
2 | Disease Models, Animal |
2 | Diarrhea |
2 | Diarrhea (diagnosis) |
2 | Dependovirus |
2 | Demyelinating Diseases (pathology) |
2 | Delivery of Health Care |
2 | Databases, Genetic |
2 | Cysteine Endopeptidases (chemistry) |
2 | Cultivar |
2 | Cross reaction |
2 | Cough (epidemiology) |
2 | Coronavirus (physiology) |
2 | Coronaviridae Infections (physiopathology) |
2 | Coronaviridae (ultrastructure) |
2 | Conservation of Natural Resources |
2 | Consensus Sequence |
2 | Computational Biology |
2 | Comorbidity |
2 | Combined immune deficiency |
2 | Circumcision |
2 | Chymotrypsin (chemistry) |
2 | Chronic Disease |
2 | Chromatography, High Pressure Liquid |